Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-22-022301
Filing Date
2022-04-28
Accepted
2022-04-28 16:25:22
Documents
1
Group Members
HC IC HOLDINGS LLCHOWARD I. HOFFENKENNETH F. CLIFFORDMETALMARK AMPLITUDE HEALTHCARE HOLDINGS LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea158994-13ga1ampli_jasper.htm SC 13G/A 72235
  Complete submission text file 0001213900-22-022301.txt   74026
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Subject) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91228 | Film No.: 22867053
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1177 AVENUE OF THE AMERICAS, FLOOR 40 NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS, FLOOR 40 NEW YORK NY 10036 2128231915
Amplitude Healthcare Holdings LLC (Filed by) CIK: 0001788269 (see all company filings)

EIN.: 843009822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A